fine line chemotherapy
Showing 9976 - 10000 of >10,000
NSCLC Trial in Beijing (PD-1 inhibitor)
Recruiting
- Non-small Cell Lung Cancer
- PD-1 inhibitor
-
Beijing, Beijing, ChinaChina
Jun 24, 2021
Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)
Recruiting
- Acute Leukemia, in Relapse
- Acute Leukemia Refractory
- CVA regimen bridging to HSCT
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Jan 4, 2022
Smoking Cessation Trial in Oklahoma City (Varenicline, Oral Nicotine Replacement Therapy (NRT), Medication Reminders)
Terminated
- Smoking Cessation
- Varenicline
- +3 more
-
Oklahoma City, OklahomaTSET Health Promotion Research Center
Oct 3, 2022
Hyperkalemia Trial in Ranica (Veltassa Oral Powder Product, Placebo)
Not yet recruiting
- Hyperkalemia
- Veltassa Oral Powder Product
- Placebo
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 29, 2023
Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)
Recruiting
- Rhabdomyosarcoma
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 13, 2022
Pressurized Intraperitoneal Aerosol Chemotherapy in Peritoneal
Completed
- Evaluate the Cost of a PIPAC Procedure and the Associated Hospital Stay in France
- PIPAC
-
Grenoble, FranceCHUGA
Apr 29, 2021
3rd Line GIST Trial in Worldwide (ST571 + BYL719)
Completed
- 3rd Line GIST
- ST571 + BYL719
-
Portland, Oregon
- +10 more
Dec 17, 2020
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Active, not recruiting
- Acute Myeloid Leukemia
- +13 more
- Azacitidine
- Gemtuzumab Ozogamicin
-
Burbank, California
- +176 more
Mar 25, 2022
Mature T-Cell and NK-Cell Tumor Trial in Hwasun-gun (Copanlisib, Gemcitabine)
Completed
- Mature T-Cell and NK-Cell Neoplasm
-
Hwasun-gun, Jeollanam-do, Korea, Republic ofChonnam National University Hwasun Hospital
Jun 9, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
COVID-19, SARS-CoV 2 Trial in Lexington (Povidone-Iodine Nasal Spray and Gargle)
Recruiting
- COVID-19
- SARS-CoV 2
- Povidone-Iodine Nasal Spray and Gargle
-
Lexington, KentuckyUniversity of Kentucky
Jun 3, 2021
Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib Trial in Shanghai (Neoadjuvant treatment)
Recruiting
- Intrahepatic Cholangiocarcinoma
- +3 more
- Neoadjuvant treatment
-
Shanghai, Shanghai, ChinaZhongshan hospital
Jul 5, 2021
Multiple Myeloma Trial in Beijing (Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone)
Recruiting
- Multiple Myeloma
- Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
-
Beijing, Beijing, ChinaPekingUMCH
Aug 15, 2021
Leukemia Trial in New York (therapeutic autologous lymphocytes, cyclophosphamide)
Active, not recruiting
- Leukemia
- therapeutic autologous lymphocytes
- cyclophosphamide
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 18, 2021
Anastomotic Stenosis Trial in Guangzhou (Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal
Recruiting
- Anastomotic Stenosis
- Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal reconstruction
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital of Sun yat-sen University
Sep 11, 2023
Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)
Withdrawn
- Recurrent Acute Myeloid Leukemia
- Bosutinib Monohydrate
- +6 more
-
Duarte, CaliforniaCity of Hope Meidcal Center
Jun 7, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in San Antonio (Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery
-
San Antonio, TexasCancer Therapy and Research Center at UTHSCSA
Dec 15, 2021
Noninvasive vs. Invasive Lung Evaluation
Completed
- Non-Small Cell Lung Cancer
- Guardant360
- (no location specified)
Apr 29, 2021
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate
Recruiting
- Metastatic Breast Cancer (MBC)
- Paclitaxel Polymeric Micelles for Injection
- +5 more
-
Nanjing, Jiangsu, China
- +2 more
Nov 21, 2023
A ctDNA Biomarker Profiling Study of NSCLC Using NGS Assays
Recruiting
- Non-Small Cell Lung Cancer
- Observation
-
Fountain Valley, California
- +3 more
Jun 22, 2022
Muscle-invasive Bladder Cancer Trial in Canada (Whole-body FDG PET-CT)
Active, not recruiting
- Muscle-invasive Bladder Cancer
- Whole-body FDG PET-CT
-
Hamilton, Ontario, Canada
- +5 more
Apr 19, 2022